Literature DB >> 30575251

Dynamic changes in insulin and glucagon during disease progression in rhesus monkeys with obesity-related type 2 diabetes mellitus.

Can Wang1,2, Yao Xiao1,2, Jue Wang1,2, Ning Hou1,2, Weiyi Cui1,2, Xiaomin Hu1,2, Fanxin Zeng1,2, Ye Yuan1,2, Dongwei Ma1,2, Xueting Sun1,2, Yan Zhang1,2,3, Wen Zheng1,2, Yuli Liu1,2, Haibao Shang1,2, Liangyi Chen1, Rui-Ping Xiao1,2,3, Xiuqin Zhang1,2.   

Abstract

AIMS: To investigate the progression of obesity-related type 2 diabetes mellitus (T2DM) in rhesus monkeys, especially dynamic changes in insulin and glucagon.
MATERIALS AND METHODS: We followed a cohort of 52 rhesus monkeys for 7 years throughout the progression of obesity-related T2DM. Intravenous glucose tolerance tests were performed every 6 months to evaluate dynamic changes in glucose, insulin and glucagon levels.
RESULTS: Obesity in rhesus monkeys increased the overall mortality and T2DM morbidity. During the progression of T2DM, glucagon remained consistently elevated, while insulin initially increased in compensation but then dropped to below normal levels when the monkeys developed overt T2DM. After a glucose challenge, both the first and second phases of insulin secretion increased during the early stage of T2DM; in later stages the first phase was delayed and the second phase was diminished.
CONCLUSION: Our findings showed that, beside the decreased insulin level, hyperglucagonaemia also plays an important role in the development of T2DM.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  continuous glucose monitoring; glucagon; insulin secretion; type 2 diabetes

Mesh:

Substances:

Year:  2019        PMID: 30575251     DOI: 10.1111/dom.13624

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  3 in total

1.  Adiposity, reproductive and metabolic health, and activity levels in zoo Asian elephant (Elephas maximus).

Authors:  Daniella E Chusyd; Tim R Nagy; Lilian Golzarri-Arroyo; Stephanie L Dickinson; John R Speakman; Catherine Hambly; Maria S Johnson; David B Allison; Janine L Brown
Journal:  J Exp Biol       Date:  2021-01-26       Impact factor: 3.312

2.  Hypolipidemic effect of Alisma orientale (Sam.) Juzep on gut microecology and liver transcriptome in diabetic rats.

Authors:  Xiaomei Xu; Lisha Li; Yamin Zhang; Xuehua Lu; Wei Lin; Shuangshuang Wu; Xia Qin; Rongqing Xu; Wenjin Lin
Journal:  PLoS One       Date:  2020-10-09       Impact factor: 3.240

3.  miR-27b Modulates Insulin Signaling in Hepatocytes by Regulating Insulin Receptor Expression.

Authors:  Asier Benito-Vicente; Kepa B Uribe; Noemi Rotllan; Cristina M Ramírez; Shifa Jebari-Benslaiman; Leigh Goedeke; Alberto Canfrán-Duque; Unai Galicia-García; Diego Saenz De Urturi; Patricia Aspichueta; Yajaira Suárez; Carlos Fernández-Hernando; Cesar Martín
Journal:  Int J Mol Sci       Date:  2020-11-17       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.